Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 9/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | CASP7 | P55210 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | ADRB1 | P08588 | 7/20 | 0.44 |
| ▸ | ADRB3 | P13945 | 5/20 | 0.44 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Broxaterol SCHEMBL8845005 | 0.98 | ADRB2 (0.45) | ADRB2LMNATSHRCYP3A4CASP7 | |
| SCHEMBL4538650 | 0.79 | ADRB2 (0.54) | ADRB2LMNATSHRCYP3A4KMT2A | |
| Carbuterol SCHEMBL18047896 | 0.78 | ADRB2 (0.45) | ADRB2TSHRKMT2AHIF1AADRB1 | |
| SCHEMBL8879834 | 0.75 | ADRB2 (0.44) | ADRB2LMNAADRB1ADRB3 | |
| SCHEMBL6074317 | 0.75 | ADRB2 (0.40) | ADRB2ADRB1ADRB3 | |
| SCHEMBL8129014 | 0.75 | ADRB2 (0.40) | ADRB2ADRB1ADRB3 | |
| SCHEMBL10341872 | 0.73 | ADRB2 (0.45) | ADRB2ADRB1ADRB3 | |
| SCHEMBL6074550 | 0.72 | ADRB2 (0.39) | ADRB2LMNATSHRCYP3A4KMT2A | |
| SCHEMBL10614263 | 0.69 | LMNA (0.66) | ADRB2LMNATSHRCYP3A4CASP7 | |
| Hydrochloric Acid SCHEMBL10614258 | 0.68 | LMNA (0.64) | ADRB2LMNATSHRCYP3A4CASP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3100 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250017878-A1 | USE OF NADOLOL TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY BLOCKAGE OF THE ARRESTIN-2 PATHWAY | CHRONIC AIRWAY THERAPEUTICS LTD (AU) | 2025-01-16 | — | — | US | claimed |
| US-20240398729-A1 | Methods and Compositions for the Treatment of Cytoplasmic Glycogen Storage Disorders | DUKE UNIVERSITY (US) | 2024-12-05 | — | — | US | claimed |
| EP-4126138-B1 | AEROSOL DELIVERY OF AT LEAST TWO LIQUID COMPOSITIONS | INVOX BELGIUM NV (BE) | 2024-10-16 | — | — | EP | claimed |
| WO-2024189434-A1 | USE OF NADOLOL TO TREAT PULMONARY SYMPTOMS ASSOCIATED WITH INFECTIONS WITH SARS-CoV-2 | CHRONIC AIRWAY THERAPEUTICS LIMITED (AU) | 2024-09-19 | — | — | WO | claimed |
| EP-1962797-B2 | POWDER COMPOSITIONS FOR INHALATION | JAGOTEC AG (CH) | 2024-05-29 | — | — | EP | claimed |
| EP-4329849-A1 | INHALER | 3D Engineering Design Limited (GB) | 2024-03-06 | — | — | EP | claimed |
| EP-4304717-A1 | USE OF NADOLOL TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY BLOCKAGE OF THE ARRESTIN-2 PATHWAY | Chronic Airway Therapeutics Limited (AU) | 2024-01-17 | — | — | EP | claimed |
| US-20230158028-A1 | COMPOUNDS AND METHODS FOR INDUCING UCP1 EXPRESSION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-05-25 | — | — | US | claimed |
| EP-4132914-A1 | COMPOUNDS AND METHODS FOR INDUCING UCP1 EXPRESSION | The Regents of the University of California (US) | 2023-02-15 | — | — | EP | claimed |
| EP-4126138-A1 | AEROSOL DELIVERY OF AT LEAST TWO LIQUID COMPOSITIONS | Softhale NV (BE) | 2023-02-08 | — | — | EP | claimed |
| EP-0486959-B1 | Pharmaceutical composition of microparticles with controlled release and process of preparing it | VECTORPHARMA INT (IT) | 1996-08-28 | — | — | EP | claimed |
| US-5536508-A | BIODEGRADABLE POLYMER AND POLYSACCHARIDE GEL AND BIOADHESIVE WITH DRUG | VECTORPHARMA INTERNATIONAL S.P.A. (IT) | 1996-07-16 | — | — | US | claimed |
| WO-1996019198-A1 | AEROSOL DRUG FORMULATIONS | ASTRA AKTIEBOLAG (SE) | 1996-06-27 | — | — | WO | claimed |
| EP-0717616-A1 | PROCESS FOR CONDITIONING SUBSTANCES | Astra Aktiebolag (SE) | 1996-06-26 | — | — | EP | claimed |
| EP-0526862-B1 | Solid pharmaceutical compositions for oral administration with prolonged gastric residence | VECTORPHARMA INT (IT) | 1996-02-14 | — | — | EP | claimed |
| WO-1995005805-A1 | PROCESS FOR CONDITIONING SUBSTANCES | ASTRA AKTIEBOLAG (SE) | 1995-03-02 | — | — | WO | claimed |
| US-5312627-A | Polymer matrix with drugs with bronchodilator agents | ZAMBON GROUP S.P.A. (IT) | 1994-05-17 | — | — | US | claimed |
| EP-0523537-A1 | Transdermal therapeutic system for the administration of drugs having bronchodilating activity | ZAMBON GROUP S.p.A. (IT) | 1993-01-20 | — | — | EP | claimed |
| EP-0486959-A1 | Pharmaceutical composition of microparticles with controlled release and process of preparing it | VECTORPHARMA INTERNATIONAL S.P.A. (IT) | 1992-05-27 | — | — | EP | claimed |
| EP-0016255-B1 | ISOXAZOLE DERIVATIVE, PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | ZAMBON S.p.A. (IT) | 1983-09-28 | — | — | EP | claimed |